Kidney Disease

Moovly Media Inc.
Latest Comments

Dr. Allen Davidoff of XORTX Therapeutics’ on developing therapies for kidney diseases and uplisting to the NASDAQ

In a recent InvestorIntel interview, Chris Thompson spoke with Dr. Allen Davidoff, CEO of XORTX Therapeutics Inc. (NASDAQ: XRTX | […]

Chris Thompson on eResearch’s Update Equity Research Report on XORTX Therapeutics Inc.

In a recent InvestorIntel interview, Tracy Weslosky spoke with Chris Thompson, President of eResearch Corp. about his 25-page Update Equity Research […]